Author

P. J. Kuehl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. Werts· 2 shared E. G. Barrett· 2 shared H. Irshad· 2 shared S. N. Langel· 2 shared A. Vitug· 1 shared C. I. Martinez· 1 shared C. J. Emig· 1 shared C. J. Ventura· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Werts

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologyMicrobiology SpectrumPeer-reviewedDec 12, 2023

Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters

P. J. Kuehl, J. Dearing, A. Werts…·S. N. Langel

This paper designs and validates an exposure system for efficient SARS-CoV-2 airborne transmission in Syrian hamsters, showing similar virological outcomes between 1:1 and 1:4 infected-to-naive ratios.

DOI 10.1128/spectrum.04717-22

mouseexperimental assay

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintOct 12, 2021

AUG-3387, a Human-Derived Monoclonal Antibody Neutralizes SARS-CoV-2 Variants and Reduces Viral Load from Therapeutic Treatment of Hamsters In Vivo

C. J. Emig, M. A. Mena, S. J. Henry…·D. J. Christensen

AUG-3387, a human monoclonal antibody, neutralizes SARS-CoV-2 variants and reduces viral load in hamsters when administered as a dry powder inhaler formulation.

DOI 10.1101/2021.10.12.464150

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivOct 3, 2021

Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model

S. N. Langel, S. Johnson, C. I. Martinez…·S. N. Tucker

This study shows oral and intranasal Ad5 SARS-CoV-2 vaccines reduce disease severity and viral transmission in golden hamsters.

DOI 10.1126/scitranslmed.abn6868

mouseexperimental assay

𝕏 PostBluesky